Interactive signaling pathways of the neuroendocrine-immune network

Chemical Immunology

Volumn 69, Issue , 1997, Pages 203-222

  Roszman, Thomas L ^a,b   Brooks, William H ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; GROWTH HORMONE; HORMONE RECEPTOR; NEUROHORMONE; PROLACTIN; THYROTROPIN;

HUMAN; IMMUNE SYSTEM; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0030664335     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058649     Document Type: Review

References (101)

1. Kalden JR, Evans MM, Irvin WJ: The effect of hypophysectomy on the immune response. Immunology 1970;18:671-679.
2. Thrasher SG, Bernardis LL, Cohen S: The immune response in hypothalamic-lesioned and hypophysectomized rats. Int Arch Allergy Appl Immunol 1971;41:813-820.
3. Tyrey L, Nalbandov AV: Influence of anterior hypothalamic lesions on circulating antibody titres in the rat. Am J Physiol 1972;22:179-185.
4. Dann JA, Wachtel SS, Rubin AL: Possible involvement of the central nervous system in graft rejection. Transplantation 1979;27:223-226.
5. Lundin PM: Action of hypophysectomy on antibody formation in the rat. Acta Pathol Microbiol Scand 1960;48:351-357.
6. Gisler RH, Schenkel-Hullinger L: Hormonal regulation of the immune response. II. Influence of pituitary and adrenal activity on immune responsiveness in vitro. Cell Immunol 1971;2:646-657.
7. Comsa J, Leonhardt H, Schwartz JA: Influence of the thymus-corticotropin-growth hormone interaction on the rejection of skin allografts in the rat. Ann NY Acad Sci 1975;249:387-401.
8. Nagy E, Berczi I: Immunodeficiency in hypophysectomized rats. Acta Endocrinol 1978;89:530-537.
9. Prentice ED, Lipscomb H, Metcalf WK, Sharp JG: Effects of hypophysectomy on DNCB-induced contact sensitivity in rats. Scand J Immunol 1976;5:955-961.
10. Saxena QB, Saxena RK, Adler WH: Regulation of natural killer activity in vivo. III. Effect of hypophysectomy and growth hormone treatment on the natural killer activity of the mouse spleen cell population. Int Arch Allergy Appl Immunol 1982;67:169-174.
11. Cross RJ, Markesbery WR, Brooks WH, Roszman TL: Hypothalamic-immune interactions. Neuromodulation of natural killer activity by lesioning of the anterior hypothalamus. Immunology 1984; 51:399-405.
12. Baroni CD, Fabris N, Bertoli G: Effects of hormones on development and function of lymphoid tissues: Synergistic action of thyroxin and somatropic hormone in pituitary dwarf mice. Immunology 1969;17:303-313.
13. Baroni CD, Pesando PC, Bertoli G: Effects of hormones on development and function of lymphoid tissue. II. Delayed development of immunological capacity in pituitary dwarf mice. Immunology 1971;21:455-461.
14. Duquesnoy RJ, Kalpaktsoglou PK, Good RA: Immunological studies on the Snell-Bagg pituitary dwarf mouse. Proc Soc Exp Biol Med 1970;133:201-206.
15. Fabris N, Pierpaoli W, Sorkin E: Hormones and the immunological capacity. III. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin Exp Immunol 1971;9:209-225.
16. Fabris N, Pierpaoli W, Sorkin E: Hormones and the immunological capacity. IV. Restorative effective of developmental hormones of lymphocytes on the immunodeficiency syndrome of the dwarf mouse. Clin Exp Immunol 1971;9:227-240.
17. Okouchi E: Thymus, peripheral tissue and immunological responsiveness of the pituitary dwarf mouse. J Physiol Soc Jpn 1976;38:325-335.
18. Murphy WJ, Durum SK, Anver MR, Longo DL: Immunologic and hematologic effects of neuroendocrine hormones: Studies on DW/J dwarf mice. J Immunol 1992;148:3799-3805.
19. Dumont F, Robert F, Bischoff P: T and B lymphocytes in pituitary dwarf Snell-Bagg mice. Immunology 1979;38:23-31.
20. Schneider GB: Immunological competence in Snell-Bagg pituitary dwarf mice: Response to the contract-sensitizing agent oxazolone. Am J Anat 1976;145:371-380.
21. Cross RJ, Bryson JS, Roszman TL: Immunologic disparity in the hypopituitary dwarf mouse. J Immunol 1992;148:1347-1352.
22. Berczi I: The effects of growth hormone and related hormones on the immune system: in Berczi I (ed): Pituitary Function and Immunity. Boca Raton, CRC Press, 1986, pp 134-159.
23. Berczi I: Immunoregulation by pituitary hormones: in Berczi I (ed): Pituitary Function and Immunity. Boca Raton, CRC Press, 1986, pp 227-240.
24. Berczi I, Nagy E: Prolactin and other lactogenic hormones: in Berczi (ed): Pituitary Function and Immunity. Boca Raton, CRC Press, 1986, pp 162-183.
25. 3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA 1986;83:5663-5667.
26. Cross RJ, Campbell J, Roszman TL: Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland. J Neuroimmunol 1989;25:29-35.
27. Cross RJ, Brooks WH, Roszman TL, Markesbery WR: Transplantation of syngeneic pituitary graft fails to restore T-cell function and thymus morphology in aged mice. Mech Aging Dev 1990;56:11-22.
28. Stein M, Schiavi RC, Camerino M: Influene of brain and behavior on the immune system. Science 1976;191:435-440.
29. Cross RJ, Markesbery WR, Brooks WH, Roszman TL: Hypothalamic-immune interactions. I. The acute effect of anterior hypothalamic lesions on the immune response. Brain Res 1980;196:79-87.
30. Roszman TL, Cross RJ, Brooks WH, Markesbery WR: Neuroimmunomodulation: Effects of neural lesions on cellular immunity; in Guillemin R, Cohn M, Melnechuk T (eds): Neural Modulation of Immunity. New York, Raven Press, 1985, pp 95-109.
31. Brooks WH, Cross RJ, Roszman TL, Markesbery WR: Neuroimmunomodulation: Neural anatomical basis for impairment and facilitiation. Ann Neurol 1982;12:56-61.
32. Goldowitz D, Scheff S, Cotman C: The specificity of reactive synaptogenesis: Comparative study in the adult rat hippocampal formation. Brain Res 1979;170:427-441.
33. Cross RJ, Brooks WH, Roszman TL, Markesbery WR: Hypothalamic-immune interactions. Effects of hypophysectomy on neuroimmunomodulation. J NeuroSci 1982;53:557-566.
34. Cross RJ, Jackson JC, Brooks WH, Sparks DL, Markesbery WR, Roszman TL: Neuroimmunomodulation: Impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology 1986;57:145-152.
35. Cross RJ, Brooks WH, Roszman TL: Modulation of T-suppressor cell activity by central nervous system catecholamine depletion. J Neurosci Res 1987;18:75-81.
36. Besedovsky HD, Sorkin E: Immunologic-neuroendocrine circuits: Physiological approaches; in Ader R (ed): Psychoneuroimmunology. New York, Academic Press, 1981, pp 545-574.
37. MacLean D, Reichlin S: Neuroendocrinology and the immune process: in Ader R (ed): Psychoneuroimmunology. New York, Academic Press, 1981, pp 405-428.
38. Blalock JE: The immune system as a sensory organ. J Immunol 1984;132:1067-1070.
39. Blalock JE, Smith EM: A complete regulatory loop between the immune and neuroendocrine systems. Fed Proc 1985;44:108-111.
40. Blalock JE, Smith EM, Meyer WJ: The pituitary-adrenocortical axis and the immune system. Clin Endocrinol Metab 1985;14:1021-1038.
41. Payan DG, McGillis JP, Goetzl E: Neuroimmunology. Adv Immunol 1986;39:299-323.
42. Plaut M: Lymphocyte hormone receptors. Annu Rev Immunol 1987;5:621-669.
43. Sibinga NES, Goldstein A: Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 1988;6:219-249.
44. Bost KL: Hormone and neuropeptide receptors on mononuclear leukocytes. Prog Allergy 1988;43: 68-83.
45. Kelley KW: Growth hormone, lymphocytes and macrophages. Biochem Pharmacol 1989;38:705-713.
46. Carr DJJ, Blalock JE: Neuropeptide hormones and receptors common to the immune and neuroendocrine systems: Bidirectional pathway of intersystem communication; in Ader R, Felten D, Cohen N (eds): Psychoneuroimmunology. San Diego, Academic Press, 1991, pp 573-588.
47. Auernhammer CJ, Strasburger CJ: Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol 1995;133:635-645.
48. Katoh M, Raguet S, Zachwieja J, Dijane J, Kelly PA: Hepatic prolactin receptors in the rat: Characterization using monoclonal antireceptor antibodies. Endocrinology 1987;120:739-749.
49. Okamura H, Zachwieja J, Raguet S, Kelly PA: Characterization and applications of monoclonal antibodies to the prolactin receptor. Endocrinology 1989;124:2499-2508.
50. Russell DH, Matrisian L, Kibler R, Larson DF, Poulos B, Magun BE: Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun 1984; 121:899-906.
51. Russell DH, Kibler R, Matrisian L, Larson D, Poulos B, Magun BE: Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin bindidng by cyclosporine. J Immunol 1985;134: 3027-3031.
52. Bellussi G, Mucciioli G, Ghe C, DiCarlo R: Prolactin binding sites in human erythrocytes and lymphocytes. Life Sci 1987;41:951-959.
53. Pellegrini I, Lebrun JJ, Ali S, Kelly PA: Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 1992;6:1023-1031.
54. Yoh CY, Phillips JT: Prolactin rreceptor exxpression by lymphoid tissues in normal and immunized rats. Mol Cell Endocrinol 1993;92:R21-R25.
55. Gala RR, Shevach EM: Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 1993;133:1617-1623.
56. Gagnrault M-C, Touraine P, Savino W, Kelly PA, Dardenne M: Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 1993;150:5673-5681.
57. Dardenne M, do Carmo M, De Moraes L, Kelly PA, Gagnerault M-C: Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytometry. Endocrinology 1994;134:2108-2114.
58. O'Neal KD, Schwarz LA, Yu-Lee LY: Prolactin receptor gene expression in lymphoid cells. Mol Cell Endocrinol 1991;82:127-135.
59. Di Carlo R, Bole-Feysot C, Gualillo O, Meli R, Nagano M, Kelly PA: Regulation of prolactin receptor mRNA expression in peripheral lymphocytes in rats in response to changes in serum concentrations of prolactin. Endocrinology 1995;136:4713-4716.
60. Lesniak MA, Roth J, Gorden P, Gavin JR: Human growth hormone radioreceptor assay using cultured human lymphocytes. Nature 1973;241:20-22.
61. 125I-human growth hormone to specific receptors in human cultured lymphocytes. J Biol Chem 1974;249:1661-1667.
62. Rapaport R, Sills IN, Green L, Barrett P, Labus J, Skuza KA, Chartoff A, Goode L, Stene M, Peterson BH: Detection of human growth hormone receptors on IM-9 cells and peripheral blood mononuclear cell subsets by flow cytometry: Correlation with growth hormone-binding protein levels. J Clin Endocrinol Metabolism 1995;80:2612-2619.
63. Gagnerault M-C, Postel-Vinay M-C, Dardenne M: Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytofluorometry. Endocrinology 1996;137:1719-1726.
64. Badolato R, Bond HM, Valerio G, Petrella A, Morrone G, Waters MJ, Venuta S, Tenore A: Differential surface expression of growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. J Clin Endocrinol Metab 1994;79:984-990.
65. Arrenbrecht S: Specific binding of growth hormone to thymocytes. Nature 1974;242:255-257.
66. Hazum E, Chang K, Cuatrecassas P: Specific nonopiate receptors for beta-endorphin. Science 1979; 205:1033-1035.
67. Mehriski JN, Mills IH: Opiate receptors on lymphocytes and platelets. Clin Immunol Immunopathol 1983;27:240-249.
68. Gaveriaux C, Peluso J, Simonin F, Laforet J, Kieffer B: Identification of κ- and δ-opioid receptor transcripts in immune cells. FEBS Lett 1995;369:272-276.
69. Lawrence DMP, El-Hamouly W, Archer S, Leary JF, Bidlack JM: Identification of κ opioid receptors in the immune system by indirect immunofluorescence. Proc Natl Acad Sci USA 1995;92:1062-1066.
70. Chuang LF, Chuang TK, Killam KF Jr, Chuang AJ, Kung H-F, Yu L, Chuang RY: Delta opioid receptor gene expression in lymphocytes. Biochem Biophys Res Commun 1994;202:1291-1299.
71. Johnson HM, Smith EM, Torres BA, Blalock JE: Neuroendocrine hormone regulation of in vitro antibody production. Proc Natl Acad Sci USA 1982;79:4171-4174.
72. Smith EM, Brosan P, Meyer WJ, Blalock JE: A corticotropin (ACTH) receptor on human mononuclear lymphocytes: Correlation with adrenal ACTH receptor activity. N Engl J Med 1987;317: 1266-1269.
73. Clarke BL, Bost KL: Differential expression of functional adenocorticotropic hormone receptors by subpopulation of lymphocytes. J Immunol 1989;143:464-469.
74. Chabaud O, Lissitzky S: Thyrotropin-specific binding to human peripheral blood monocytes and polymorphonuclear leukocytes. Mol Cell Endocrinol 1977;7:79-87.
75. Coutelier JP, Kehrl JH, Bellur SS, Kohn LD, Nokins AL, Prabhakar BS: Binding and functional effects of thyroid-stimulating hormone on human immune cells. J Clin Immunol 1990;10:204-210.
76. Bernton EW: prolactin and immune host defenses. Prog Neuroendocrinimmunol 1989;2:21-29.
77. Besedovsky H, Del Ray A, Sorkin E: Regulatory immune-neuro-endocrine feedback loops; in Berczi I (ed): Pituitary Function and Immunity. Boca Raton, CRC Press, 1986, pp 241-249.
78. Roszman TL, Carlson SL: Neural-immune interactions: Circuits and networks. Prog Neuroendocrinimmunol 1991;4:69-78.
79. Cross RJ, Roszman TL: Neuroendocrine modulation of immune function: The role of prolactin. Prog Neuroendocrinimmunol 1989;2:17-20.
80. Johnson HM, Torres BA: Immunoregulatory properties of neuroendocrine peptide hormones. Prog Allergy, Basel, Karger, 1988, vol 43, pp 37-67.
81. Murphy WJ, Rui H, Longo DL: Effects of growth hormone and prolactin immune development and function. Life Sci 1995;57:1-14.
82. Besedovsky HO, Del Ray A: Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 1996;17:64-102.
83. Fu YK, Arkins S, Wang BS, Kelley KW: A novel role of growth hormone and insulin-like growth factor-1: Priming neutrophils for superoxide anion secretion. J Immunol 1991;146:1602-1608.
84. Janeway CA, Bottomly K: Signals and signs for lymphocyte responses. Cell 1994;76:275-285.
85. Jenkins MK, Ashwell JD, Schwartz RH: Allogeneic non-T helper cells restore the responsiveness of normal T-cell clones stimulated with antigen and chemically modified antigen-presenting cells. J Immunol 1988;140:3324-3330.
86. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 1994;76:241-251.
87. Schwartz RH: Models of T-cell anergy: Is there a common molecular mechanism. J Exp Med 1996; 184:1-8.
88. Clevenger CV, Torigoe T, Reed JC: Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line. J Biol Chem 1994;269:5559-5565.
89. Dusanter-Fourt I, Muller O, Ziemiecki A, Mayeux P, Drucker B, Kjiane J, Wilks A, Harpur AG, Fischer S, Gisselbrecht S: Identification of JAK protein tyrosine kinases as signaling molecules for prolactin: Functional analysis of prolactin receptor and prolactin-erythropoietin receptor chimera expressed in lymphoid cells. EMBO J 1994;13:2583-2591.
90. Palestine AG, Muellenberg-Coulombre CG, Kim MK, Gelato MC, Nussenblatt RB: Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat. J Clin Invest 1987;79:1078-1081.
91. Buskila D, Sukenik S, Shoenfeld Y: The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991;26:118-123.
92. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE: Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991;147:3780-3787.
93. Riskind PN, Massacesi L, Doolittle TH, Hauser SL: The role of prolactin in autoimmune demyelination: Suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 1991;29:542-547.
94. Jara LJ, Lavalle C, Fraga A, Gomez-Sanchez C, Silveria LH, Martinez-Osuna P, Germain BF, Espinoza LR: Prolactin, immunoregulation, and autoimmune diseases, Semin Arthritis Rheum 1991;20:273-284.
95. Hawkins TA, Gala RR, Dunbar JC: Prolactin modulates the incidence of diabetes in male and female NOD mice. FASEB J 1993;7:A20.
96. Carlson SL, Brooks WH, Roszman TL: Neurotransmitter-lymphocyte interactions: Dual receptor modulation of lymphocyte proliferation and cAMP production. J Neuroimmunol 1989;24:155-162.
97. Carlson SL, Trauth K, Brooks WH, Roszman TL: Enhancement and adaptation of beta-adrenergic-induced cAMP accumulation in T-cells. J Cell Physiol 1994;161:39-48.
98. Koshland DE, Goldbeter A, Stock JB: Amplification and adaptation in regulatory and sensory systems. Science 1982;217:220-225.
99. Altman A, Coggeshell KM, Mustelin T: Molecular events mediating T-cell activation. Adv Immunol 1990;48:227-360.
100. 2 either alone or in combination. Cell Mol Neurobiol 1992;14:1-7.
101. 2 modulate T-cell receptor signaling through a cAMP-independent mechanism. Cell Immunol 1996; 169:117-124.